Company profile
Amazonas Florestal, Ltd
OTC: AZFL · Healthcare · Drug Manufacturers - Specialty & Generic
#662 of 1,418 Healthcare companies by revenuetop-decile growth
EA Score
——FH —DQ —GM —SS 31
v0.1 · 5/100 weight · pillars only
↑ revenue growth (YoY), return on assets · ↓ growth stability, workforce scale
Methodology →Revenue TTM
$12.4M
Rev growth YoY (TTM)
+2819.6%
Net income (FY)
$494.4k
Employees
5
as of 2026-08-29
Market cap
$25.1k
as of 2026-08-29
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$7.7M$7.7M2021
Net income$494.4k$494.4k2021
Operating income$872.3k$872.3k2021
Total assets$7.7M$7.7M2021
Liabilities$2.8M$2.8M2021
Equity$4.9M$4.9M2021
Revenue trend
FY2012 – FY2021 · USD
FY12
FY13
FY14
FY15
FY16
FY17
FY18
FY21
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Amazonas Florestal, Ltd’s revenue?
Amazonas Florestal, Ltd booked $7.7M in FY2021 revenue, growing 13836% year over year — faster than 100% of Healthcare companies we track, at a 6.5% net margin.
Peers · Healthcare
Crinetics Pharmaceuticals, Inc.53DBolt Biotherapeutics, Inc.39DBeyond Air, Inc.42DCOSCIENS Biopharma Inc.43DCompuMed, Inc.69BXenon Pharmaceuticals Inc.56CNeighbors
Miami-Dade →Key facts
CEORicardo Cortez
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
HeadquartersMiami, FL
ExchangeOTC: AZFL
Employees5
IPO date2013-01-04
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.